HEADER HYDROLASE 16-NOV-17 6EZX TITLE CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-CHLORO-N-(1-CYANOCYCLOPROPYL)- TITLE 2 5-OXO-17-OXA-4-AZATRICYCLO[16.2.2.06,11]DOCOSA-1(21),6,8,10,14, TITLE 3 18(22),19-HEPTAENE-3-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN L1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CATHEPSIN L,MAJOR EXCRETED PROTEIN,MEP; COMPND 5 EC: 3.4.22.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSL, CTSL1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.W.BANNER,J.BENZ,A.KUGLSTATTER REVDAT 2 09-MAY-18 6EZX 1 JRNL REVDAT 1 11-APR-18 6EZX 0 JRNL AUTH M.GIROUD,U.DIETZEL,L.ANSELM,D.BANNER,A.KUGLSTATTER,J.BENZ, JRNL AUTH 2 J.B.BLANC,D.GAUFRETEAU,H.LIU,X.LIN,A.STICH,B.KUHN,F.SCHULER, JRNL AUTH 3 M.KAISER,R.BRUN,T.SCHIRMEISTER,C.KISKER,F.DIEDERICH,W.HAAP JRNL TITL REPURPOSING A LIBRARY OF HUMAN CATHEPSIN L LIGANDS: JRNL TITL 2 IDENTIFICATION OF MACROCYCLIC LACTAMS AS POTENT RHODESAIN JRNL TITL 3 AND TRYPANOSOMA BRUCEI INHIBITORS. JRNL REF J. MED. CHEM. V. 61 3350 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29590750 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01869 REMARK 2 REMARK 2 RESOLUTION. 2.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0112 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.34 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 85.4 REMARK 3 NUMBER OF REFLECTIONS : 15249 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 840 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.34 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.40 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1067 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.68 REMARK 3 BIN R VALUE (WORKING SET) : 0.3730 REMARK 3 BIN FREE R VALUE SET COUNT : 66 REMARK 3 BIN FREE R VALUE : 0.3880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3331 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 82.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.21000 REMARK 3 B22 (A**2) : 4.25000 REMARK 3 B33 (A**2) : -0.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -5.47000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.883 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.356 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.321 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 28.624 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.904 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3513 ; 0.010 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4756 ; 1.318 ; 1.958 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 432 ; 6.112 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 168 ;37.575 ;25.060 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 541 ;18.319 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ; 9.108 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 466 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2781 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 220 REMARK 3 ORIGIN FOR THE GROUP (A): 14.0190 -7.7700 9.6060 REMARK 3 T TENSOR REMARK 3 T11: 0.2728 T22: 0.0950 REMARK 3 T33: 0.1681 T12: 0.0064 REMARK 3 T13: 0.1930 T23: -0.0260 REMARK 3 L TENSOR REMARK 3 L11: 8.5600 L22: 4.5492 REMARK 3 L33: 8.7164 L12: 3.4794 REMARK 3 L13: 4.0019 L23: 1.2402 REMARK 3 S TENSOR REMARK 3 S11: 0.0135 S12: 0.0829 S13: -0.0942 REMARK 3 S21: -0.1801 S22: 0.1286 S23: 0.0387 REMARK 3 S31: -0.0166 S32: -0.0696 S33: -0.1422 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 220 REMARK 3 ORIGIN FOR THE GROUP (A): 40.7320 2.4320 36.9610 REMARK 3 T TENSOR REMARK 3 T11: 0.2771 T22: 0.2538 REMARK 3 T33: 0.3287 T12: -0.0136 REMARK 3 T13: 0.1081 T23: -0.0929 REMARK 3 L TENSOR REMARK 3 L11: 10.2643 L22: 4.1281 REMARK 3 L33: 12.6216 L12: 2.2342 REMARK 3 L13: 8.1260 L23: 3.2547 REMARK 3 S TENSOR REMARK 3 S11: -0.3020 S12: 0.1950 S13: -0.0025 REMARK 3 S21: 0.4051 S22: 0.3394 S23: -0.5878 REMARK 3 S31: -0.4260 S32: 0.5632 S33: -0.0374 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EZX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1200007542. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XPREP REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15249 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.340 REMARK 200 RESOLUTION RANGE LOW (A) : 46.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.4 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.59900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.1 M BIS-TRIS, PH 6.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.70850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 174 REMARK 465 THR A 175 REMARK 465 GLU A 176 REMARK 465 SER B 174 REMARK 465 THR B 175 REMARK 465 GLU B 176 REMARK 465 SER B 177 REMARK 465 ASP B 178 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN B 179 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 2 170.64 -47.96 REMARK 500 SER A 4 110.82 -160.28 REMARK 500 GLN A 21 45.79 -80.69 REMARK 500 GLU A 96 -161.62 -120.92 REMARK 500 LYS A 117 45.67 -79.37 REMARK 500 LYS A 147 -58.26 -124.79 REMARK 500 ASP A 178 -97.58 -128.35 REMARK 500 ASP A 204 36.01 75.73 REMARK 500 ALA A 214 53.20 -141.89 REMARK 500 GLU B 63 44.71 -104.07 REMARK 500 ASP B 79 35.74 -75.29 REMARK 500 ASN B 80 -24.80 -156.22 REMARK 500 ALA B 93 23.70 48.62 REMARK 500 LYS B 117 64.89 -69.88 REMARK 500 MET B 195 65.84 -102.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C7Q A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide C7Q B 301 and CYS B REMARK 800 25 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6EZP RELATED DB: PDB DBREF 6EZX A 1 220 UNP P07711 CATL1_HUMAN 114 333 DBREF 6EZX B 1 220 UNP P07711 CATL1_HUMAN 114 333 SEQRES 1 A 220 ALA PRO ARG SER VAL ASP TRP ARG GLU LYS GLY TYR VAL SEQRES 2 A 220 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 A 220 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 A 220 ARG LYS THR GLY ARG LEU ILE SER LEU SER GLU GLN ASN SEQRES 5 A 220 LEU VAL ASP CYS SER GLY PRO GLN GLY ASN GLU GLY CYS SEQRES 6 A 220 ASN GLY GLY LEU MET ASP TYR ALA PHE GLN TYR VAL GLN SEQRES 7 A 220 ASP ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 A 220 GLU ALA THR GLU GLU SER CYS LYS TYR ASN PRO LYS TYR SEQRES 9 A 220 SER VAL ALA ASN ASP THR GLY PHE VAL ASP ILE PRO LYS SEQRES 10 A 220 GLN GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL GLY SEQRES 11 A 220 PRO ILE SER VAL ALA ILE ASP ALA GLY HIS GLU SER PHE SEQRES 12 A 220 LEU PHE TYR LYS GLU GLY ILE TYR PHE GLU PRO ASP CYS SEQRES 13 A 220 SER SER GLU ASP MET ASP HIS GLY VAL LEU VAL VAL GLY SEQRES 14 A 220 TYR GLY PHE GLU SER THR GLU SER ASP ASN ASN LYS TYR SEQRES 15 A 220 TRP LEU VAL LYS ASN SER TRP GLY GLU GLU TRP GLY MET SEQRES 16 A 220 GLY GLY TYR VAL LYS MET ALA LYS ASP ARG ARG ASN HIS SEQRES 17 A 220 CYS GLY ILE ALA SER ALA ALA SER TYR PRO THR VAL SEQRES 1 B 220 ALA PRO ARG SER VAL ASP TRP ARG GLU LYS GLY TYR VAL SEQRES 2 B 220 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 B 220 ALA PHE SER ALA THR GLY ALA LEU GLU GLY GLN MET PHE SEQRES 4 B 220 ARG LYS THR GLY ARG LEU ILE SER LEU SER GLU GLN ASN SEQRES 5 B 220 LEU VAL ASP CYS SER GLY PRO GLN GLY ASN GLU GLY CYS SEQRES 6 B 220 ASN GLY GLY LEU MET ASP TYR ALA PHE GLN TYR VAL GLN SEQRES 7 B 220 ASP ASN GLY GLY LEU ASP SER GLU GLU SER TYR PRO TYR SEQRES 8 B 220 GLU ALA THR GLU GLU SER CYS LYS TYR ASN PRO LYS TYR SEQRES 9 B 220 SER VAL ALA ASN ASP THR GLY PHE VAL ASP ILE PRO LYS SEQRES 10 B 220 GLN GLU LYS ALA LEU MET LYS ALA VAL ALA THR VAL GLY SEQRES 11 B 220 PRO ILE SER VAL ALA ILE ASP ALA GLY HIS GLU SER PHE SEQRES 12 B 220 LEU PHE TYR LYS GLU GLY ILE TYR PHE GLU PRO ASP CYS SEQRES 13 B 220 SER SER GLU ASP MET ASP HIS GLY VAL LEU VAL VAL GLY SEQRES 14 B 220 TYR GLY PHE GLU SER THR GLU SER ASP ASN ASN LYS TYR SEQRES 15 B 220 TRP LEU VAL LYS ASN SER TRP GLY GLU GLU TRP GLY MET SEQRES 16 B 220 GLY GLY TYR VAL LYS MET ALA LYS ASP ARG ARG ASN HIS SEQRES 17 B 220 CYS GLY ILE ALA SER ALA ALA SER TYR PRO THR VAL HET C7Q A 301 32 HET C7Q B 301 32 HETNAM C7Q (3~{S},14~{E})-19-CHLORANYL-~{N}-[1-(IMINOMETHYL) HETNAM 2 C7Q CYCLOPROPYL]-5-OXIDANYLIDENE-17-OXA-4- HETNAM 3 C7Q AZATRICYCLO[16.2.2.0^{6,11}]DOCOSA-1(21),6,8,10,14, HETNAM 4 C7Q 18(22),19-HEPTAENE-3-CARBOXAMIDE FORMUL 3 C7Q 2(C25 H26 CL N3 O3) FORMUL 5 HOH *54(H2 O) HELIX 1 AA1 ARG A 8 GLY A 11 5 4 HELIX 2 AA2 SER A 24 GLY A 43 1 20 HELIX 3 AA3 SER A 49 SER A 57 1 9 HELIX 4 AA4 GLU A 63 GLY A 67 5 5 HELIX 5 AA5 LEU A 69 ASN A 80 1 12 HELIX 6 AA6 GLN A 118 VAL A 129 1 12 HELIX 7 AA7 HIS A 140 PHE A 145 1 6 HELIX 8 AA8 ASN A 207 ILE A 211 5 5 HELIX 9 AA9 ARG B 8 GLY B 11 5 4 HELIX 10 AB1 SER B 24 THR B 42 1 19 HELIX 11 AB2 SER B 49 SER B 57 1 9 HELIX 12 AB3 GLY B 58 GLY B 61 5 4 HELIX 13 AB4 GLU B 63 GLY B 67 5 5 HELIX 14 AB5 LEU B 69 ASP B 79 1 11 HELIX 15 AB6 ASN B 101 LYS B 103 5 3 HELIX 16 AB7 GLN B 118 VAL B 129 1 12 HELIX 17 AB8 HIS B 140 PHE B 145 1 6 HELIX 18 AB9 ASN B 207 ILE B 211 5 5 SHEET 1 AA1 3 VAL A 5 ASP A 6 0 SHEET 2 AA1 3 HIS A 163 GLY A 171 -1 O TYR A 170 N VAL A 5 SHEET 3 AA1 3 ILE A 132 ILE A 136 -1 N VAL A 134 O VAL A 165 SHEET 1 AA2 5 VAL A 5 ASP A 6 0 SHEET 2 AA2 5 HIS A 163 GLY A 171 -1 O TYR A 170 N VAL A 5 SHEET 3 AA2 5 TYR A 182 LYS A 186 -1 O LYS A 186 N LEU A 166 SHEET 4 AA2 5 TYR A 198 ALA A 202 -1 O VAL A 199 N VAL A 185 SHEET 5 AA2 5 ILE A 150 TYR A 151 1 N TYR A 151 O LYS A 200 SHEET 1 AA3 2 LEU A 83 ASP A 84 0 SHEET 2 AA3 2 SER A 105 ALA A 107 -1 O VAL A 106 N LEU A 83 SHEET 1 AA4 2 PHE A 112 ASP A 114 0 SHEET 2 AA4 2 SER A 216 PRO A 218 -1 O TYR A 217 N VAL A 113 SHEET 1 AA5 3 VAL B 5 ASP B 6 0 SHEET 2 AA5 3 HIS B 163 PHE B 172 -1 O TYR B 170 N VAL B 5 SHEET 3 AA5 3 ILE B 132 ILE B 136 -1 N ILE B 132 O VAL B 167 SHEET 1 AA6 5 VAL B 5 ASP B 6 0 SHEET 2 AA6 5 HIS B 163 PHE B 172 -1 O TYR B 170 N VAL B 5 SHEET 3 AA6 5 LYS B 181 LYS B 186 -1 O LEU B 184 N VAL B 168 SHEET 4 AA6 5 TYR B 198 ALA B 202 -1 O MET B 201 N TRP B 183 SHEET 5 AA6 5 ILE B 150 TYR B 151 1 N TYR B 151 O LYS B 200 SHEET 1 AA7 2 LEU B 83 ASP B 84 0 SHEET 2 AA7 2 SER B 105 ALA B 107 -1 O VAL B 106 N LEU B 83 SHEET 1 AA8 2 VAL B 113 ILE B 115 0 SHEET 2 AA8 2 ALA B 215 TYR B 217 -1 O ALA B 215 N ILE B 115 SSBOND 1 CYS A 22 CYS A 65 1555 1555 2.03 SSBOND 2 CYS A 56 CYS A 98 1555 1555 2.06 SSBOND 3 CYS A 156 CYS A 209 1555 1555 2.06 SSBOND 4 CYS B 22 CYS B 65 1555 1555 2.05 SSBOND 5 CYS B 56 CYS B 98 1555 1555 2.08 SSBOND 6 CYS B 156 CYS B 209 1555 1555 2.06 LINK SG CYS A 25 C18 C7Q A 301 1555 1555 1.76 LINK SG CYS B 25 C18 C7Q B 301 1555 1555 1.76 SITE 1 AC1 11 GLY A 23 CYS A 25 TRP A 26 GLY A 67 SITE 2 AC1 11 GLY A 68 LEU A 69 ALA A 135 MET A 161 SITE 3 AC1 11 ASP A 162 HIS A 163 ALA A 214 SITE 1 AC2 18 GLN B 19 GLY B 23 SER B 24 TRP B 26 SITE 2 AC2 18 ALA B 27 PHE B 28 SER B 29 GLU B 63 SITE 3 AC2 18 GLY B 67 GLY B 68 LEU B 69 MET B 70 SITE 4 AC2 18 ALA B 135 MET B 161 ASP B 162 HIS B 163 SITE 5 AC2 18 GLY B 164 ALA B 214 CRYST1 59.340 43.417 86.498 90.00 96.14 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016852 0.000000 0.001813 0.00000 SCALE2 0.000000 0.023032 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011628 0.00000